Weirdness score:
🕒 10 hrs agoRegeneron Snaps Up Bankrupt 23andMe’s 15M DNA Kits in $256M Privacy Showdown
Regeneron’s $256 million purchase of bankrupt 23andMe brings 15M DNA kits under new control, with promises to honor privacy. The deal, announced May 19, 2025, includes court oversight and excludes Lemonaid Health, adding a surreal corporate twist to the saga. “Good hands,” says analyst.
Court-appointed oversight will scrutinize Regeneron's stewardship of 23andMe’s massive DNA trove. The 2023 data breach still echoes as lawmakers demand strict data protection. DNA privacy policy, a hot SEO topic, now hinges on Regeneron’s transparency—imagine 15 million saliva kits boxed for review.
23andMe’s 2023 hacking incident exposed genetic data of millions, fueling the privacy scrutiny now shadowing Regeneron’s acquisition.
